Posted on August 14th, 2009 by Kelley Luckstein
Atrial Fibrillation patients at risk of stroke may benefit from percutaneous closure of the left atrial appendage (LAA) as an alternative to long-term warfarin therapy, according to a study in the Aug. 15 issue of The Lancet.
David R. Holmes, M.D., of the Mayo Clinic College of Medicine in Rochester, Minn., and colleagues enrolled 707 patients with non-valvular atrial defibrillation who were 75 years or older or had had a stroke or transient ischemic attack, congestive heart failure, diabetes, or hypertension.
Modern Medicine 8/14/2009
You must be logged-in to the site to post a comment.